Related Experiment Videos
Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease
Patricia Gomez-Bougie1, Lisa Oliver, Steven Le Gouill
1Département de recherche en cancérologie, Equipe 5 labélisée L N C 2005, Institut de biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France.
Oncogene
|August 11, 2005
Summary
Melphalan treatment for multiple myeloma (MM) triggers apoptosis by downregulating Mcl-1 and releasing Bim, leading to cancer cell death. This study clarifies melphalan
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Multiple myeloma (MM) is a fatal plasma-cell malignancy.
- Melphalan is a common MM treatment with poorly understood mechanisms.
- Mcl-1 protein neutralizes Bim's proapoptotic function in myeloma cells.
Purpose of the Study:
- To elucidate the molecular mechanisms of melphalan-induced apoptosis in multiple myeloma.
- To investigate the role of Mcl-1 and Bim interactions in melphalan's efficacy.
Main Methods:
- Analysis of protein expression levels (Mcl-1, Bcl-x(L), Bim isoforms) in melphalan-sensitive myeloma cells.
- Assessment of caspase cleavage and protein complex formation (Mcl-1/Bim, Bcl-2/Bim).
- Evaluation of Bax activation and cytochrome c release.
Main Results:
- Melphalan drastically downregulates Mcl-1L, Bcl-x(L), and BimEL, with lesser effects on BimL and BimS.
- Melphalan treatment leads to caspase-mediated cleavage of Mcl-1 and Bim.
- Melphalan disrupts the Mcl-1/Bim complex, releasing Bim to activate Bax and induce apoptosis.
Conclusions:
- Melphalan induces apoptosis in multiple myeloma by disrupting the Mcl-1/Bim complex.
- Released Bim isoforms promote apoptosis through Bax activation and cytochrome c release.
- Cleaved Mcl-1 and Bim fragments may amplify the apoptotic cascade in response to melphalan.